Shailender Bhatia, MD
19 Years of Experience
Physician
Seattle Cancer Care Alliance
Seattle Cancer Care Alliance
Associate Professor, Department of Medicine, Division of Medical Oncology
University of Washington School of Medicine
University of Washington School of Medicine
Physician
UW Medicine
UW Medicine
Assistant Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Clinical expertise
Skin, Renal
Skin, Renal
Located at
Medical Degree
All India Institute of Medical Sciences, New Delhi, India
All India Institute of Medical Sciences, New Delhi, India
Residency
University of Connecticut Health Center
University of Connecticut Health Center
Fellowship
University of Washington
University of Washington
Board Certification
Medical Oncology, 2008, American Board of Internal Medicine; Hematology (Internal Medicine), 2008, American Board of Internal Medicine
Medical Oncology, 2008, American Board of Internal Medicine; Hematology (Internal Medicine), 2008, American Board of Internal Medicine
Other
Internship, University of Connecticut Health Center
Internship, University of Connecticut Health Center
Languages
English, Hindi, Panjabi
Your care team
At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and
treatments.
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.
Clinical trials
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
A Study to Investigate the Safety and Efficacy of Nivolumab in Virus-associated Tumors (CheckMate358)
Study No:
NCT02488759
Phase:
Phase I/II
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
Study No:
NCT03553836
Phase:
Phase III
A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma
Study No:
NCT03599713
Phase:
Phase II